I AM A ...

I accept the Privacy Statement and I agree to comply with it. View our Privacy Statement.

This website uses cookies to better understand user behavior and provide the best experience. By continuing to use this website, you are consenting to the placement and retrieval of cookies on your computer by this website. Cookies will be stored for 90 days.

Never show this.

Ask a Portfolio Manager

January 2023

Episode 2

How Can Competitive Advantages Help Companies Manage Through Times of Uncertainty?

In this session, Richard puts FAs’ questions to Jensen Investment Portfolio Managers Eric Schoenstein and Allen Bond. Topics covered include:

  • Which industries and companies are well-positioned in the current environment
  • Consumer behavior changes in 2023 and what impact they might that have on the companies in the Growth Portfolio
  • What trends may be the most potentially impactful in healthcare right now.

Meet Your Host

Richard Clark

Richard leads Jensen’s business development across the advisor and intermediary channels.

Learn more: Richard discusses Jensen’s approach to investment management and client service

Meet the Portfolio Managers

Eric Schoenstein

Eric joined Jensen Investment Management in 2002 and currently serves as the chief investment officer, with primary responsibility for portfolio management and strategy across all of Jensen’s products. Eric spent nearly fourteen years with Arthur Andersen LLP as a senior audit manager, providing a wide variety of services to clients of all sizes in both the public and private sectors. He earned a BS in business administration with a focus in accounting from Oregon State University. Eric serves as a trustee for the Oregon State University Foundation Board of Trustees and is currently the board chair. He is also a past president of the Oregon State University Alumni Association. He serves as a director for the Western Golf Association, which administers and oversees the Evans Scholars Foundation. He currently serves as treasurer on the Executive Committee for the Oregon Golf Association, which he previously served as president.

Learn more: A history of quality investing

Allen Bond

Allen joined Jensen Investment Management in 2007. Allen is responsible for coordinating fundamental research conducted across the investment teams. Additionally, he maintains his portfolio management and analyst responsibilities. Allen joined Jensen from Washington Mutual, where he held the position of credit analyst. In that role, Allen performed fundamental analysis on investment-grade corporate bond issuers. Prior to Washington Mutual, he was a high-yield credit analyst and trader for Columbia Management Group. Allen began his career as a trader at Ferguson Wellman Capital Management. He earned a BS in business and an MBA from the University of Oregon. He is a CFA charterholder. Allen is a past president of CFA Society Portland.

Learn more: Volatile Markets are an important reminder about three big investment risks

Click here to view Jensen Quality Growth Strategy’s current holdings.

The company discussion in this presentation is solely intended to illustrate the application of our investment approach. The specific security identified is taken from a representative account of the Jensen Quality Growth Equity Composite and does not represent all of the securities purchased and sold for the Strategy. Our views expressed herein are subject to change and should not be construed as a recommendation or offer to buy or sell any security and are not designed or intended as a basis or determination for making any investment decision for any security. Our discussions should not be construed as an indication that an investment in a security has been or will be profitable, or that the investment recommendations or decisions we make in the future will be profitable or will equal the investment performance of any security discussed herein.

Past performance is no guarantee of future results. The information contained herein represents management’s current expectation of how the Jensen Quality Growth Strategy will continue to be operated in the near term; however, management’s plans and policies in this respect may change in the future. In particular, (i) policies and approaches to portfolio monitoring, risk management, and asset allocation may change in the future without notice, and (ii) economic, market and other conditions could cause the Strategy and accounts invested in the Strategy to deviate from stated investment objectives, guidelines, and conclusions stated herein.

Certain information contained in this material represents or is based upon forward-looking statements, which can be identified by the use of terminology such as “may”, “will”, “should”, “expect”, “anticipate”, “target”, “project”, “estimate”, “intend”, “continue”, or “believe” or the negatives thereof or other variations thereon or comparable terminology. Due to various risks and uncertainties, actual events or results or the actual performance of a client account may differ materially from those reflected or contemplated in such forward-looking statements.

This information is current as of January 26, 2023 and is subject to change at any time, based on market and other conditions. Jensen Investment Management, Inc. is an investment adviser registered under the Investment Advisers Act of 1940. Registration with the SEC does not imply any level of skill or training. Although taken from reliable sources, Jensen cannot guarantee the accuracy of the information received from third parties. 

Interested in Learning More?

Related Insights

Jensen News & Insights

15 March 2023
Around the Bend: What to Tell Clients in Difficult Markets
How can advisers put the current market environment in perspective to help their clients prepare for whatever comes next?
Insights, Videos
9 March 2023
Animal Spirits Podcast: Investing in Quality Growth
Jensen Portfolio Manager Kevin Walkush joins the Animal Sprits Podcast to discuss quality growth investing, active management, return on equity, and more.
9 March 2023
Press Release: Three New Equity Ownership Shareholders
We are pleased to welcome Alexandria Sorosky, MaryAnn Dahl and Todd Schoen as the most recent additions to firm ownership.
2 March 2023
Pfizer: Short-Term Noise or Long-Term Benefits?
Pfizer stands to lose approximately $17B in sales over the next several years due to the loss of exclusivity on several large drug franchises. Find out why we believe this short-term noise may not outweigh the benefits for long-term investors.
15 February 2023
Press Release: Promotions of Adam Dunn and Jeff Wilson
We are pleased to announce the promotion of Adam Dunn to Director of Trading and Jeff Wilson to Portfolio Manager.
13 February 2023
How Diageo Is Serving Up Higher Profits with a Focus on Premium Spirits
With its marketing and distribution muscle, Diageo (DEO) can get its products in stores and bars everywhere. They also have deep pockets to buy up artisanal brands that have already built a following.
7 February 2023
Ask a Portfolio Manager: Episode 2
Portfolio Managers Eric Schoenstein and Allen Bond answer questions about the most important things FAs can tell their clients right now.
31 January 2023
With Covid Stumbles Behind It, AstraZeneca’s Superior Pipeline Can Shine
AstraZeneca can weather periodic hiccups with a diverse portfolio of blockbuster drugs, including a COVID-19 vaccine.
17 January 2023
With a Massive Vaccine War Chest, Pfizer’s Future Is Brighter Than Ever
The Covid Vaccine Isn’t the Most Exciting Thing About Pfizer (It’s What They Plan to Do Next)